Skip to main content
George NG

George NG

Chief Executive Officer, Processa Pharmaceuticals, Inc.
United States
Mr. Ng is a seasoned life sciences industry executive. He is currently CEO of Processa Pharmaceuticals. Mr. Ng previously was Board Director, President & Chief Operating Officer at Calidi Biotherapeutics, Inc. He is also a partner at PENG Life Science Ventures (PENG LSV). Mr. Ng has founded and/or led multiple companies, including Scilex Pharmaceuticals, Inc. (now, Scilex Holding Co (NASDAQ:SCLX)), where he was Co-Founder and President, and led the company through development, clinical trials, NDA submission, FDA approval, $140 million financing, commercial launch of the company’s first FDA-approved drug product, and ultimate company sale. He has also held various other senior management positions, including Board Director, Managing Director, Chief Administrative Officer, Chief Business Officer, Corporate Secretary, Chief Legal Officer, General Counsel, Chief Compliance Officer and Chief Intellectual Property Counsel, with publicly-traded and private, global biotechnology and pharmaceutical companies, including Sorrento Therapeutics, Inc. (NASDAQ: SRNE), BioDelivery Sciences International, Inc. (NASDAQ: BDSI), Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) and Alpharma, Inc. (NYSE:ALO), which is now, a part of Pfizer Inc.

Double Helix


Supporting Bank Sponsor


Premier Sponsors

Conference Sponsors


Media Partner


Sign up for updates

Stay up-to-date on the BIO CEO and Investor Conference via email.